Abstract WP147: Cell-Free Fat Extract Promotes Angiogenesis in a Mouse Model of Cerebral Ischemia

Hui Shen,Guo-Yuan Yang,Yaohui Tang,Zhijun Zhang,Ziyou Yu,Wenjie Zhang
DOI: https://doi.org/10.1161/str.51.suppl_1.wp147
IF: 10.17
2020-01-01
Stroke
Abstract:Background: Adipose tissue and its derivatives including adipose-derived stem cells and stromal vascular fraction (SVF) showed effective in the treatment of ischemic stroke. However, cell-based therapy for clinical application has been hindered by limitations such as safety, immunogenicity issues, and difficulties in cell preservation, transportation, and phenotype control. Here, we aimed to produce a cell-free extract directly from human fat tissue and evaluate its potential therapeutic efficacy for treating ischemic stroke. Methods: Cell-free aqueous extract from human fat tissue was obtained using mechanical emulsification method. Twenty adult CD-1 mice were subjected to 60-minute middle cerebral artery occlusion. Immediately after ischemia, 0.1 ml fat extract was intravenously injected into ischemic mice through tail vein every other day for 14 days. Brain atrophy volume and neurobehavioral outcomes were examined at 14 days after focal ischemia. The occurrence of angiogenesis was evaluated by immunostaining and ELISA, and growth factors contained in the fat extract was analyzed to explore the molecular mechanism of fat extract treatment. Results: Our results showed that brain atrophy volume reduced and neurobehavioral outcomes improved at 3 ,7 and 14 days of focal ischemia in the fat extract treated mice compared to the controls ( p <0.05). Furthermore, fat extract treatment increased microvessel density at 14 days after focal ischemia (p<0.05). ELISA showed that fat extract contained high levels of several growth factors such as HGF, VEGF, bFGF, BDNF, and GDNF. Conclusions: We developed a novel cell-free therapeutic agent, fat extract, produced from human adipose tissue. The fat extract contained high level of growth factors such as HGF, VEGF, bFGF, BDNF, and GDNF, which plays important role of promoting angiogenesis and reduced ischemic brain injury in the mouse brain, suggesting that the fat extract is a novel cell-free therapeutic agent in the treatment of ischemic stroke.
What problem does this paper attempt to address?